Trial Profile
To compare safety and efficacy of Endeavor Resolute with Resolute Integrity zotarolimus-eluting stents in patients in patients undergone percutaneous coronary intervention
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Mar 2017
Price :
$35
*
At a glance
- Drugs Zotarolimus (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- 26 Mar 2017 New trial record